Risultati della ricerca - Mark Hyman Rapaport
- Mostra 1 - 20 risultati su 32
- Vai alla pagina seguente
-
1
-
2
-
3
-
4
Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings di Boadie W. Dunlop, Jaclyn Gray, Mark Hyman Rapaport
Pubblicazione 2017Artigo -
5
-
6
-
7
Insomnia and suicidal ideation in nonaffective psychosis di Brian J. Miller, Carmen Black, Mark Hyman Rapaport, P.F. Buckley, W. Vaughn McCall
Pubblicazione 2018Artigo -
8
-
9
-
10
Massage Therapy for Psychiatric Disorders di Mark Hyman Rapaport, Pamela J. Schettler, Erika R. Larson, Dedric Carroll, Margaret Sharenko, James H. Nettles, Becky Kinkead
Pubblicazione 2018Artigo -
11
Treating Major Depression by Creating Positive Expectations for the Future: A Pilot Study for the Effectiveness of Future‐Directed Therapy (FDT) on Symptom Severity and Quality of... di Jennice Vilhauer, Sabrina Young, Chanel Kealoha, Josefine Borrmann, Waguih William IsHak, Mark Hyman Rapaport, Narineh Hartoonian, Jim Mirocha
Pubblicazione 2011Artigo -
12
-
13
Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Stud... di C.E.M. Griffiths, Maurizio Fava, Andrew H. Miller, James Russell, Susan Ball, Wen Xu, Nayan Acharya, Mark Hyman Rapaport
Pubblicazione 2017Artigo -
14
-
15
Diet, Stress and Mental Health di J. Douglas Bremner, Kasra Moazzami, Matthew T. Wittbrodt, Jonathon A. Nye, Bruno B. Lima, Charles F. Gillespie, Mark Hyman Rapaport, Bradley D. Pearce, Amit Shah, Viola Vaccarino
Pubblicazione 2020Revisão -
16
Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators di Stefania Lamon‐Fava, Minying Liu, Boadie W. Dunlop, Becky Kinkead, Pamela J. Schettler, Jennifer C. Felger, Thomas R. Ziegler, Maurizio Fava, David Mischoulon, Mark Hyman Rapaport
Pubblicazione 2023Artigo -
17
Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation di Mark Hyman Rapaport, Georges M. Gharabawi, Carla M. Canuso, Ramy Mahmoud, Martin B. Keller, Cynthia A. Bossie, Ibrahim Turkoz, Robert Lasser, Amy Loescher, Philippe Bouhours, Fiona Dunbar, Charles B. Nemeroff
Pubblicazione 2006Artigo -
18
Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders di J. Douglas Bremner, Nil Z. Gurel, Matthew T. Wittbrodt, Md Mobashir Hasan Shandhi, Mark Hyman Rapaport, Jonathon A. Nye, Bradley D. Pearce, Viola Vaccarino, Amit Shah, Jeanie Park, Marom Bikson, Omer T. Inan
Pubblicazione 2020Revisão -
19
Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressi... di Stefania Lamon‐Fava, Jisun So, David Mischoulon, Thomas R. Ziegler, Boadie W. Dunlop, Becky Kinkead, Pamela J. Schettler, Andrew A. Nierenberg, Jennifer C. Felger, Krishna Rao Maddipati, Maurizio Fava, Mark Hyman Rapaport
Pubblicazione 2020Artigo -
20
Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial di Becky Kinkead, Pamela J. Schettler, Erika R. Larson, Dedric Carroll, Margaret Sharenko, James H. Nettles, Sherry A. Edwards, Andrew H. Miller, Mylin A. Torres, Boadie W. Dunlop, Jeffrey J. Rakofsky, Mark Hyman Rapaport
Pubblicazione 2017Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Psychiatry
Psychology
Internal medicine
Biology
Pathology
Alternative medicine
Schizophrenia (object-oriented programming)
Depression (economics)
Economics
Macroeconomics
Major depressive disorder
Gene
Genetics
Clinical psychology
Mood
Placebo
Bipolar disorder
Environmental health
Genotype
Single-nucleotide polymorphism
Genome-wide association study
Population
Psychosis
Randomized controlled trial
Amygdala
Anxiety
Biochemistry
Cognition
Eicosapentaenoic acid